Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Ellis

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Patient Education and Counseling|August 30, 2008
Women's perceptions of their treatment decision-making about breast cancer treatmentMary Ann O'Brien, Timothy J Whelan, Cathy Charles, et al.
Clinical Lung Cancer|December 3, 2016
Radiotherapy With Curative Intent in Patients With Early-stage, Medically Inoperable, Non-Small-cell Lung Cancer: A Systematic ReviewConrad B Falkson, Emily T Vella, Edward Yu, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2021
ALK inhibitor-induced bradycardia: A systematic-review and meta-analysisFilipe Cirne, Shijie Zhou, Coralea Kappel, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|September 20, 2011
Physician-related facilitators and barriers to patient involvement in treatment decision making in early stage breast cancer: perspectives of physicians and patientsMary Ann O'Brien, Peter M Ellis, Timothy J Whelan, et al.
Clinical Lung Cancer|June 5, 2012
A phase I open-label dose-escalation study of intravenous BI 2536 together with pemetrexed in previously treated patients with non-small-cell lung cancerPeter M Ellis, Quincy S Chu, Natasha Leighl, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2014
NCIC CTG IND.190 phase I trial of dalotuzumab (MK-0646) in combination with cisplatin and etoposide in extensive-stage small-cell lung cancerPeter M Ellis, Frances A Shepherd, Scott A Laurie, et al.
The Oncologist|July 19, 2019
Adjuvant Trastuzumab Therapy: Can We Balance Efficacy and Safety?Carly C Barron, Nidhi Kumar Tyagi, Muhammad Mustafa Alhussein, et al.
Clinical Lung Cancer|April 16, 2025
Systematic Review for the Follow-up of Curatively Treated Patients With Lung CancerYaron Shargall, Emily T Vella, Maria Elisabeth Del Giudice, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Phase II trial of OGX-011 in combination with docetaxel in metastatic breast cancerStephen Chia, Susan Dent, Susan Ellard, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 26, 2012
Understanding the needs of lung cancer patients during the pre-diagnosis phaseDavid Wiljer, Tara Walton, Julie Gilbert, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Patient Education and Counseling|August 30, 2008
Women's perceptions of their treatment decision-making about breast cancer treatmentMary Ann O'Brien, Timothy J Whelan, Cathy Charles, et al.
Clinical Lung Cancer|December 3, 2016
Radiotherapy With Curative Intent in Patients With Early-stage, Medically Inoperable, Non-Small-cell Lung Cancer: A Systematic ReviewConrad B Falkson, Emily T Vella, Edward Yu, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2021
ALK inhibitor-induced bradycardia: A systematic-review and meta-analysisFilipe Cirne, Shijie Zhou, Coralea Kappel, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|September 20, 2011
Physician-related facilitators and barriers to patient involvement in treatment decision making in early stage breast cancer: perspectives of physicians and patientsMary Ann O'Brien, Peter M Ellis, Timothy J Whelan, et al.
Clinical Lung Cancer|June 5, 2012
A phase I open-label dose-escalation study of intravenous BI 2536 together with pemetrexed in previously treated patients with non-small-cell lung cancerPeter M Ellis, Quincy S Chu, Natasha Leighl, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2014
NCIC CTG IND.190 phase I trial of dalotuzumab (MK-0646) in combination with cisplatin and etoposide in extensive-stage small-cell lung cancerPeter M Ellis, Frances A Shepherd, Scott A Laurie, et al.
The Oncologist|July 19, 2019
Adjuvant Trastuzumab Therapy: Can We Balance Efficacy and Safety?Carly C Barron, Nidhi Kumar Tyagi, Muhammad Mustafa Alhussein, et al.
Clinical Lung Cancer|April 16, 2025
Systematic Review for the Follow-up of Curatively Treated Patients With Lung CancerYaron Shargall, Emily T Vella, Maria Elisabeth Del Giudice, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Phase II trial of OGX-011 in combination with docetaxel in metastatic breast cancerStephen Chia, Susan Dent, Susan Ellard, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 26, 2012
Understanding the needs of lung cancer patients during the pre-diagnosis phaseDavid Wiljer, Tara Walton, Julie Gilbert, et al.
Pageof 10